ALLERGAN (PRINGY)
Manufacturer adverse-event records for ALLERGAN come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2014–2026 · mid-book · quiet Death-code · injury-heavy
Injury-mix signature
ALLERGAN leans injury-heavy in event_type mix
Injury-coded event_type share is 84.8% (injury-heavy tercile) beside 0.05% Death-coded (quiet). Volume band: mid.
What the Injury-mix reading shows for ALLERGAN (PRINGY)
The standout signal for ALLERGAN (PRINGY) is Injury-mix: 84.8% Injury-coded (injury-heavy) beside 0.05% Death-coded, on a mid-book footprint.
Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for ALLERGAN. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.
Reports span 2 device types, led in this extract by Injury at 7,387 (84.8% of event_type total). Peak single-year volume reaches 1,581 reports across 13 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (2)
| Device | Reports |
|---|---|
| Implant, Dermal, For Aesthetic Use | 8,707 |
| Prosthesis, Breast, Inflatable, Internal, Saline | 1 |
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.